|
 |

> return to people page
| ANITA HJELMELAND, PhD |
Education
Ph.D in Pharmacology, Duke University, 2003
BS in Biochemistry , North Carolina State University, 1997
Publications
Targeting Interleukin 6 Signaling Suppresses Glioma Stem Cell Survival and Tumor Growth.
Wang H, Lathia JD, Wu Q, Wang J, Li Z, Heddleston JM, Eyler CE, Elderbroom J, Gallagher J, Schuschu J, Macswords J, Cao Y, McLendon RE, Wang XF, Hjelmeland AB, Rich JN.
Stem Cells. 2009 Aug 5;27(10):2393-2404.
NDRG4 is required for cell cycle progression and survival in glioblastoma cells.
Schilling SH, Hjelmeland AB, Radiloff DR, Liu IM, Wakeman TP, Fielhauer JR, Foster EH, Lathia JD, Rich JN, Wang XF, Datto MB.
J Biol Chem. 2009 Sep 11;284(37):25160-9. E
Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.
Li Z, Bao S, Wu Q, Wang H, Eyler C, Sathornsumetee S, Shi Q, Cao Y, Lathia J, McLendon RE, Hjelmeland AB, Rich JN.
Cancer Cell. 2009 Jun 2;15(6):501-13
|
|
 |
 |
Project Staff
Department of Stem Cell and Regenerative Medicine
2111 E 96th Street
Cleveland, OH 44195
Phone: (216) 636-1667
Fax: (216) 636-5454
|
|
|
|